2007
DOI: 10.1016/j.nmd.2007.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
76
1
3

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 90 publications
(85 citation statements)
references
References 232 publications
(360 reference statements)
5
76
1
3
Order By: Relevance
“…The distance increased by 4 m in the 2MWT, which is comparable to studies in participants with non-NMDs [5][6][7][8][9], but a learning effect in the 2MWT has never been investigated before in patients with NMDs. The increase of 11 m in the 6MWT from test to retest is a little lower than the 17-24 m reported in other NMD-studies [4][5][6][7][8][9][10][11][12][13][14][15]. The difference in walking variability across studies might be due to different sample sizes, neuromuscular diseases, disease severity and methods.…”
Section: Discussionmentioning
confidence: 68%
See 2 more Smart Citations
“…The distance increased by 4 m in the 2MWT, which is comparable to studies in participants with non-NMDs [5][6][7][8][9], but a learning effect in the 2MWT has never been investigated before in patients with NMDs. The increase of 11 m in the 6MWT from test to retest is a little lower than the 17-24 m reported in other NMD-studies [4][5][6][7][8][9][10][11][12][13][14][15]. The difference in walking variability across studies might be due to different sample sizes, neuromuscular diseases, disease severity and methods.…”
Section: Discussionmentioning
confidence: 68%
“…Previous studies have recommended to use the best of 2-3 6MWTs to eliminate the learning effect [1,4]. However, multiple tests are not always feasible to perform, and are time-consuming and fatiguing for patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The ability to walk at a specified distance is a quick, simple, and inexpensive way to evaluate physical function. Walking is also a critical important component of the quality of life because it is highly necessary to accomplish the daily life activities and reflects patient's capacity [151,152]. The validity study of the 2-min walk test has been conducted in neuromuscular diseases, and it was put to use in recent years since its period of implementation is short and it does not cause fatigue [153,154].…”
Section: Assessment Of Aerobic (Functional) Capacitymentioning
confidence: 99%
“…L'évaluation de la capacité à marcher est incontournable pour obtenir un portrait clinique dans la DM1. Le test de marche de 6 minutes est un outil dont la validité et la sensibilité ont été démontrées (Redelmeier et al, 1997;Rostagno et al, 2003;Alameri et al, 2007;Kierkegaard & Tollback, 2007;Rostagno & Gensini, 2008;de Souza et al, 2009;Pollentier et al, 2010). La procédure, assez simple, requiert que le sujet évalué marche sur la plus grande distance possible pendant une période de 6 minutes.…”
Section: 7unclassified